Trial Profile
An Open-label, Randomized, Two-sequence, Multiple-dose, Crossover Study to Evaluate Drug-drug Interaction Following Oral Administration of Telmisartan/Amlodipine and Atorvastatin in Healthy Adult Volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Mar 2018
Price :
$35
*
At a glance
- Drugs Amlodipine/telmisartan (Primary) ; Atorvastatin (Primary)
- Indications Hyperlipidaemia; Hypertension
- Focus Pharmacokinetics
- Sponsors Jeil Pharmaceutical
- 13 Mar 2018 New trial record